Arun V J։ The Hidden Risks in Every Blood Bag
Arun V J, The Leader of Transfusion Medicine at Malabar Medical College, shared a post on LinkedIn:
”Why You Should Not Transfuse Blood?
I know, I know—we call it ‘Liquid Gold.’
We’re told it’s the ultimate gift of life. And in a trauma bay or a massive hemorrhage, it absolutely is.
But after years of watching clinical trends, I’m seeing a dangerous habit: ‘Frooti’ Prescribing.
Some clinicians are tossing units of blood at patients just because their ‘numbers are a little low,’ without weighing the long-term biological tax.
Before you or a loved one signs that consent form for a non-emergency transfusion, you need to know what’s actually in that bag:
- The ‘Clean’ Blood Myth
We live in 2026, but no test is perfect.
While NAT (Nucleic Acid Testing) is the gold standard for catching viruses early, many centers still rely on ELISA.
ELISA has a wider ‘window period.’
If a donor was infected recently, the test might stay silent.
You are playing a statistical game with infections the lab literally cannot see yet.
- The TRALI and Acute Risks
It’s not just a “simple rash.” TRALI (Transfusion-Related Acute Lung Injury) is the leading cause of transfusion-related death.
Your lungs suddenly fill with fluid. Your immune system sees the foreign blood and goes into a full-scale riot.
- The ‘Shadow Side’: TRIM
This is the one they rarely mention.
Transfusion-Related Immunomodulation (TRIM) is a fundamental reprogramming of your immune system.
When you pump in 500ml of foreign biological material, your “security team” (T-cells and NK cells) gets distracted.
The Fallout:
Post-Op Infections: Transfused patients have significantly higher rates of hospital-acquired pneumonia. Your body is too busy processing the ‘foreigner’ to fight the actual bacteria.
Cancer Recurrence: NK cells hunt cancer. When TRIM shuts them down, dormant cells can find a ‘green light’ to grow.
Future Debt: Taking blood today can “sensitize” you, making your body more likely to reject a life-saving kidney or heart transplant 20 years from now.
The Mentor’s Advice:
Don’t be a passive recipient.
If a transfusion is suggested and you are stable:
- Ask for the Trigger: Is this for a symptom (shortness of breath) or just a number?
- Request ‘Restrictive’ Strategy: Modern science shows staying at a hemoglobin of 7 or 8 is often safer than forcing it to 10.
- Ask about NAT: Know the quality of the screening.
Your body is better at surviving a little bit of anemia than it is at surviving a total immune shutdown.
Respect the gift, but fear the misuse.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention